Evaluate the Safety and Tolerability of ZKLJ02 Injection in Healthy Chinese Research Participants
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZKLJ02 Injection in Healthy Chinese Research Participants (NCT07638098) | Yunnan Zhongke Longjin Biotechnology Co.,Ltd. | 2025-08-11 |
Track Evaluate the Safety and Tolerability of ZKLJ02 Injection in Healthy Chinese Research Participants automatically
Every clearance here is in the API, with alerts when new ones post.